TPD & Induced Proximity Summit Leaderboard
  • Tuesday, July 21, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 569

Author

Pharma Journalist 8947 posts 0 comments

Janssen Seeks to Expand Use of TREMFYA (guselkumab) in the Treatment of Adults With Active Psoriatic…

Oct 24, 2019
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a Type II Variation Application to the European Medicines Agency (EMA) seeking first-in-class…
Read More...

Exclusive Interview with Cedric Gysel Johnson and Johnson’s Cedric Gysel for Pre-Filled Syringe and…

Oct 23, 2019
SMi Reports: Exclusive interview with Cedric Gysel from Johnson and Johnson ahead of the 12th annual Pre-Filled Syringe and Injectable Drug Devices conference being held in London on…
Read More...

PDS Biotechnology Completes Manufacturing of Clinical Batches of PDS0101

Oct 23, 2019
PDS Biotechnology Corporation announced that it has completed manufacturing of clinical batches of PDS0101 with its partner BSP Pharmaceuticals S.p.A, a leading manufacturer of…
Read More...

Moderna Receives FDA Fast Track Designation for Propionic Acidemia Program (mRNA-3927)

Oct 23, 2019
Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,…
Read More...

Zealand Pharma expands its peptide platform with acquisition of Encycle Therapeutics

Oct 23, 2019
Zealand Pharma A/S, a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces the acquisition of Encycle…
Read More...

Takeda Acquires License for First-In-Class Celiac Disease Therapy from COUR Pharma Following…

Oct 23, 2019
Takeda Pharmaceutical Company Limited and COUR Pharmaceutical Development Company, Inc. announced that Takeda has acquired an exclusive global license to develop and commercialize the…
Read More...

Biogen Plans Regulatory Filing for Aducanumab in Alzheimer’s Disease Based on New Analysis of Larger…

Oct 23, 2019
Biogen and Eisai, Co., Ltd. announced that, after consulting with the U.S. Food and Drug Administration (FDA), Biogen plans to pursue regulatory approval for aducanumab, an…
Read More...

Bryn Pharma Partners with Aptar Pharma for Nasal Epinephrine Treatment

Oct 22, 2019
Bryn Pharma announced that it has entered into an agreement with Aptar Pharma, a leading drug delivery systems provider, for the supply and worldwide exclusive right to use Aptar's…
Read More...

Moberg Pharma and DongKoo Sign Agreement for MOB-015 in the Republic of Korea

Oct 22, 2019
Moberg Pharma AB has signed a distribution agreement with DongKoo Bio & Pharma Co., Ltd for MOB-015 in the Republic of Korea. Under the agreement DongKoo is granted exclusive rights…
Read More...

Odonate Therapeutics announces completion of enrollment in CONTESSA metastatic breast cancer trial

Oct 22, 2019
Odonate Therapeutics, a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced the…
Read More...
Prev Next
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Organon Expands Australia Biosimilar Partnership With Samsung Bioepis
  • Telix Opens Advanced Cancer Radiopharmaceutical Facility in Melbourne
  • FDA Approves First Oral PCSK9 Inhibitor for High Cholesterol
  • FDA Grants Full Approval to Fabhalta for IgA Nephropathy
  • EU Approves Wegovy Pill for Obesity Treatment

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.